Profile

Dr. Nindhana Paranthaman, MD, MBA

Summit Therapeutics

Contact Details

Summit Therapeutics

Edit Your Contact Info

Volunteer Bio  

Entrepreneurial physician executive passionate about developing and commercializing novel cancer therapies with a proven track record of navigating complex corporate environments to generate meaningful patient outcomes

Biotechnology & pharmaceutical industry expertise spans oncology and immunology with multibillion-dollar blockbuster drugs in global and US-based roles of increasing responsibility
- Notable work on global development and launch of the world’s first KRAS inhibitor (sotorasib) for lung cancer
- Currently managing a portfolio of therapies in lung, skin and pediatric cancers and leading first in class anti-TIGIT antibody (tiragolumab) US launch plans at Genentech